May 8, 2020 / 3:26 PM / a month ago

BRIEF-Shanghai Fosun Pharmaceutical's Unit Gets Acceptance Notice For Hematologic Malignancies Tablet

May 8 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd :

* UNIT GETS ACCEPTANCE FOR FCN-338 TABLET DEVELOPED TO TREAT HEMATOLOGIC MALIGNANCIES Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below